openPR Logo
Press release

Global Heparin Market: Segment Snapshot and Table of Content (2017-2027)

12-12-2017 09:54 AM CET | Health & Medicine

Press release from: Transparency Market Research

Global Heparin Market: Segment Snapshot and Table of Content

TMR has envisaged the global heparin market to earn an around US$16.3 bn by the end of 2025 while rising at a CAGR of 6.2% during the forecast time frame 2017-2025. In 2017, the market earned an approximately US$10.1 bn. With respect to segmentation by product, low molecular weight heparin (LMWH) could account for a colossal share in the market by the completion of the forecast period. Regionally, North America has been anticipated to secure a lion’s share while expanding at a 5.6% CAGR.

Global Heparin Market: Commercial Applications Increase Owing to Laboratory Monitoring Ease and Rapid Onset of Action, finds TMR

Read Report overview @ https://www.transparencymarketresearch.com/heparin-market.html

The global protein expression technology market is segmented on the basis of expression system, product type, by Formulation, by Geography and region.

As studied by the analysts, the world heparin market could be segmented on the basis of product, source, and formulation. By product, the market is predicted to encompass three segments, viz. unfractionated heparin (UFH), low molecular weight heparin (LMWH) and ultra-low molecular weight heparin (ULMWH). Amongst these products, LMWH had accounted for a king’s share in the recent past and is a widely used heparin to this date.

Generic and biosimilar drug manufacturers are expected to be empowered with growth opportunities birthing from the patent expiration of a majority of LMWHs. Since LMWH does not cross the placenta, it has been recommended as one of the most appropriate forms of heparin to be used during pregnancy by the Royal College of Obstetrics and Gynecology (RCOG) and National Institute for Health and Care Excellence (NICE). However, ULMWH is still used as a more novel therapeutic among the products in the heparin family.

Request Sample Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=803

Summary of Table of Content :

1 Preface
2 Assumptions and Research Methodology
3 Executive Summary: Global Heparin Market
4 Market Overview
5 Global Heparin Market Analysis and Forecasts, By Product Type
6 Global Heparin Market Analysis and Forecasts, By Source
7 Global Heparin Market Analysis and Forecasts, By Formulation
8 Global Heparin Market Analysis and Forecasts, By Region
9 North America Heparin Market Analysis and Forecasts
10 Europe Heparin Market Analysis and Forecasts
11 Asia Pacific Heparin Market Analysis and Forecasts-
12 Middle East & Africa Heparin Market Analysis
13 Latin America Heparin Market Analysis
14 Heparin Market Analysis by Muslim & Non-Muslim Countries-
15 Competitive Landscape

Request to Browse Full Table of Content, figure and Tables @
https://www.transparencymarketresearch.com/report-toc/803

About TMR

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact

Transparency Market Research
State Tower
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
TMR Blog: http://www.theglobalhealthnews.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Heparin Market: Segment Snapshot and Table of Content (2017-2027) here

News-ID: 855921 • Views:

More Releases from Transparency Market Research

Neuromorphic Chip Market to Reach USD 2.3 Billion by 2034, Driven by Explosive AI Adoption and Next-Generation Edge Computing Innovations | TMR
Neuromorphic Chip Market to Reach USD 2.3 Billion by 2034, Driven by Explosive A …
The global Neuromorphic Chip Market is entering a defining phase of exponential growth, propelled by a surge in artificial intelligence (AI) applications, edge computing expansion, and rapid advancements in next-generation semiconductor technologies. According to the latest industry analysis, the market-valued at US$ 56.2 Mn in 2023-is projected to expand at an extraordinary CAGR of 40.1% from 2024 to 2034, reaching an estimated US$ 2.3 Bn by 2034. Examine key highlights and
Neuroprotection Market Surges Toward USD 60.1 Bn by 2031 as Global Neurological Disease Burden Accelerates | TMR
Neuroprotection Market Surges Toward USD 60.1 Bn by 2031 as Global Neurological …
The global Neuroprotection Market continues to gain unprecedented momentum as healthcare systems worldwide intensify their focus on combating neurological disorders. With a valuation of US$ 31.6 Bn in 2022, the market is on track to reach US$ 60.1 Bn by 2031, expanding at a robust 7.5% CAGR during the forecast period. The rise in dementia, stroke, Parkinson's, epilepsy, and multiple sclerosis-combined with aging demographics and a surge in sedentary lifestyles-has
Neuroregeneration Therapy Market Set to Reach USD 64.8 Bn by 2034, Driven by Innovations in Gene Editing, Stem Cell Therapy, and AI-Based Neuromedicine | TMR
Neuroregeneration Therapy Market Set to Reach USD 64.8 Bn by 2034, Driven by Inn …
The global neuroregeneration therapy market continues to chart steady, sustained growth. The increasing incidence of neurological disorders-including Alzheimer's disease, Parkinson's disease, multiple sclerosis, Huntington's disease, stroke, diabetic neuropathy, and spinal cord injuries-is significantly influencing market expansion. In 2023, the market was worth US$ 37.0 Bn, demonstrating rising demand for treatments capable of repairing or regenerating damaged neural tissue. Examine key highlights and takeaways from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86322 With breakthroughs
Neuroscience Market Set to Reach USD 41.6 Bn by 2031 Driven by Technological Advances in Brain Mapping, AI, and Portable Neuroimaging | TMR
Neuroscience Market Set to Reach USD 41.6 Bn by 2031 Driven by Technological Adv …
The global neuroscience market stood at US$ 30.1 Bn in 2022, reflecting the significant technological and clinical potential of neurological research. Projected to grow at a CAGR of 3.7% from 2023 to 2031, the industry is expected to reach US$ 41.6 Bn by 2031. Rising prevalence of neurodegenerative diseases, advancements in neuroimaging, integration of artificial intelligence, and the emergence of brain-computer interfaces are shaping the next decade of neuroscience innovation. Examine

All 5 Releases


More Releases for Heparin

Heparin (Heparin Sodium and Heparin Calcium) Market Size, Overview And Forecast …
"The Global Heparin (Heparin Sodium and Heparin Calcium) Market Size is projected to reach at a CAGR of 3.4% during 2024-2032." Global Heparin (Heparin Sodium and Heparin Calcium) market Size, Status, and Forecast for the 2024-2032. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Heparin (Heparin Sodium and Heparin Calcium) Market including
Heparin (Heparin Sodium and Heparin Calcium) Market explores demand trends, grow …
"𝐄𝐦𝐩𝐨𝐰𝐞𝐫𝐢𝐧𝐠 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬𝐞𝐬 𝐰𝐢𝐭𝐡 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐯𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐟𝐨𝐫 𝐒𝐦𝐚𝐫𝐭𝐞𝐫 𝐃𝐞𝐜𝐢𝐬𝐢𝐨𝐧-𝐌𝐚𝐤𝐢𝐧𝐠" The global Heparin (Heparin Sodium and Heparin Calcium) market is anticipated to grow from USD 1,202 Million in 2023 to USD 1,509 Million by 2033, at a CAGR of 3.3 % during the forecast period. Heparin (Heparin Sodium and Heparin Calcium) 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞, 𝐒𝐜𝐨𝐩𝐞, 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝟐𝟎𝟐𝟒-𝟐𝟎𝟑𝟑 𝐫𝐞𝐩𝐨𝐫𝐭 𝐡𝐚𝐬 𝐛𝐞𝐞𝐧 𝐢𝐧𝐜𝐥𝐮𝐝𝐞𝐝 𝐢𝐧 𝐄𝐱𝐚𝐜𝐭𝐢𝐭𝐮𝐝𝐞 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐚𝐧𝐜𝐲'𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐜𝐨𝐥𝐥𝐞𝐜𝐭𝐢𝐨𝐧. Heparin (Heparin Sodium and Heparin Calcium) Market
Heparin Market Report 2023 | Increasing the Advantages of Low Molecular Weight H …
According to Precision Business Insights (PBI), the latest report the global heparin market size was valued at USD 7,923.7 million in 2022 and is projected to grow at a 2.8% CAGR during the forecast period 2023 to 2029. The efficacy of these drugs as an anticoagulant is one of the key factors expected to drive global market growth. Furthermore, undeniable factors such as technological advancement and introducing of new products
Heparin Market
The heparin market refers to the global market for heparin, a blood-thinning medication that is commonly used in the prevention and treatment of blood clots. Heparin is typically derived from the mucous membranes of animals such as pigs and cows, and it is commonly used in a variety of medical settings, including hospitals, clinics, and home care settings. The heparin market has experienced steady growth over the past few years, driven
Global Heparin(Heparin Sodium and Heparin Calcium) Market drivers, restraints, g …
Latest industry research report on: Global Heparin(Heparin Sodium and Heparin Calcium) Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts This report studies the global Heparin(Heparin Sodium and Heparin Calcium) market status and forecast, categorizes the global Heparin(Heparin Sodium and Heparin Calcium) market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China,
Heparin Market: Rapid Growth of Heparin Market Anticipated in Several European N …
Europe is among the major regions contributing to the global heparin market owing to its developed economy and high prevalence of coagulation disorders. According to the Ageing Report published by the European Commission in 2015, the percentage of population aged above 65 years is expected to increase from 21.0% in 2013 to 32.0% in 2060. Aging is directly proportional to the rising incidence of venous thromboembolism (VTE) diseases such as